{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:48:33Z","timestamp":1782460113509,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["KAKENHI Grant Number 24K11940"],"award-info":[{"award-number":["KAKENHI Grant Number 24K11940"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01511-0","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:16:25Z","timestamp":1782458185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Factors for Cancer-Specific Survival after Recurrence in Chemo-Na\u00efve Stage I\u2013III Colorectal Cancer"],"prefix":"10.1007","volume":"57","author":[{"given":"Tomoyuki","family":"Momma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0966-4746","authenticated-orcid":false,"given":"Hirokazu","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kitabori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Katagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ujiie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Chida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"3","key":"1511_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"1511_CR2","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1007\/s10147-025-02899-8","volume":"30","author":"Y Kinugasa","year":"2025","unstructured":"Kinugasa Y, Uehara K, Yamaguchi K, Saito Y, Murofushi K, Sugai T, Ishiguro M, Ishihara S, Ueno H, Oka S, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer. Int J Clin Oncol. 2025;30(12):2410\u201363.","journal-title":"Int J Clin Oncol"},{"issue":"1\u20132","key":"1511_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/ans.13254","volume":"86","author":"PE Teloken","year":"2016","unstructured":"Teloken PE, Ransom D, Faragher I, Jones I, Gibbs P, Platell C. Recurrence in patients with stage I colorectal cancer. ANZ J Surg. 2016;86(1\u20132):49\u201353.","journal-title":"ANZ J Surg"},{"issue":"3","key":"1511_CR4","first-page":"e513","volume":"17","author":"C Kim","year":"2018","unstructured":"Kim C, Kim WR, Kim KY, Chon HJ, Beom SH, Kim H, Jung M, Shin SJ, Kim NK, Ahn JB. Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection. Clin Colorectal Cancer. 2018;17(3):e513\u20138.","journal-title":"Clin Colorectal Cancer"},{"issue":"2","key":"1511_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1158\/2767-9764.CRC-23-0512","volume":"4","author":"TC Boute","year":"2024","unstructured":"Boute TC, Swartjes H, Greuter MJE, Elferink MAG, van Eekelen R, Vink GR, de Wilt JHW, Coupe VMH. Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based Study. Cancer Res Commun. 2024;4(2):607\u201316.","journal-title":"Cancer Res Commun"},{"issue":"14","key":"1511_CR6","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1200\/JCO.2007.15.8261","volume":"26","author":"MJ O\u2019Connell","year":"2008","unstructured":"O\u2019Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, Andre T, Haller DG, Sargent DJ. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set. J Clin Oncol. 2008;26(14):2336\u201341.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1511_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaoncol.2016.5469","volume":"3","author":"FA Sinicrope","year":"2017","unstructured":"Sinicrope FA, Shi Q, Allegra CJ, Smyrk TC, Thibodeau SN, Goldberg RM, Meyers JP, Pogue-Geile KL, Yothers G, Sargent DJ, et al. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers: A Secondary Analysis of 2 Randomized Clinical Trials. JAMA Oncol. 2017;3(4):472\u201380.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1511_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/ags3.12483","volume":"5","author":"H Sawayama","year":"2021","unstructured":"Sawayama H, Miyamoto Y, Hiyoshi Y, Ogawa K, Kato R, Akiyama T, Kiyozumi Y, Yoshida N, Baba H. Overall survival after recurrence in stage I-III colorectal cancer patients in accordance with the recurrence organ site and pattern. Ann Gastroenterol Surg. 2021;5(6):813\u201322.","journal-title":"Ann Gastroenterol Surg"},{"issue":"1","key":"1511_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12957-023-03015-8","volume":"21","author":"H Pu","year":"2023","unstructured":"Pu H, Chen Y, Shen R, Zhang Y, Yang D, Liu L, Dong X, Yang G. Influence of the initial recurrence site on prognosis after radical surgery for colorectal cancer: a retrospective cohort study. World J Surg Oncol. 2023;21(1):137.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1511_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00423-024-03308-w","volume":"409","author":"I Ise","year":"2024","unstructured":"Ise I, Kawai K, Nakano D, Takao M, Natsume S, Kato H, Nakamori S, Dejima A, Yamaguchi T. Hazard function analysis of prognosis after recurrent colorectal cancer. Langenbecks Arch Surg. 2024;409(1):123.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"1511_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00595-021-02336-z","volume":"52","author":"H Furuke","year":"2022","unstructured":"Furuke H, Arita T, Kuriu Y, Shimizu H, Kiuchi J, Yamamoto Y, Konishi H, Morimura R, Shiozaki A, Ikoma H, et al. The survival after recurrence of colorectal cancer: a retrospective study focused on time to recurrence after curative resection. Surg Today. 2022;52(2):239\u201350.","journal-title":"Surg Today"},{"issue":"9","key":"1511_CR12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/DCR.0000000000001167","volume":"61","author":"K Kawai","year":"2018","unstructured":"Kawai K, Nozawa H, Hata K, Kiyomatsu T, Tanaka T, Nishikawa T, Sugihara K, Watanabe T. Nomogram Predicting Survival After Recurrence in Patients With Stage I to III Colon Cancer: A Nationwide Multicenter Study. Dis Colon Rectum. 2018;61(9):1053\u201362.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"1511_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12885-022-09615-z","volume":"22","author":"S Abe","year":"2022","unstructured":"Abe S, Kawai K, Nozawa H, Sasaki K, Murono K, Emoto S, Ozawa T, Yokoyama Y, Nagai Y, Anzai H, et al. Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study. BMC Cancer. 2022;22(1):486.","journal-title":"BMC Cancer"},{"key":"1511_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1477-7819-12-155","volume":"12","author":"KM Chan","year":"2014","unstructured":"Chan KM, Wu TH, Cheng CH, Lee WC, Chiang JM, Chen JS, Wang JY. Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis. World J Surg Oncol. 2014;12:155.","journal-title":"World J Surg Oncol"},{"issue":"13","key":"1511_CR15","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S1470-2045(14)70486-3","volume":"15","author":"HJ Schmoll","year":"2014","unstructured":"Schmoll HJ, Twelves C, Sun W, O\u2019Connell MJ, Cartwright T, McKenna E, Saif M, Lee S, Yothers G, Haller D. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials. Lancet Oncol. 2014;15(13):1481\u201392.","journal-title":"Lancet Oncol"},{"issue":"19","key":"1511_CR16","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1200\/JCO.23.01326","volume":"42","author":"C Gallois","year":"2024","unstructured":"Gallois C, Shi Q, Pederson LD, Andre T, Iveson TJ, Sobrero AF, Alberts S, de Gramont A, Meyerhardt JA, George T, et al. Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT\/IDEA Pooled Analysis of 12 Trials. J Clin Oncol. 2024;42(19):2295\u2013305.","journal-title":"J Clin Oncol"},{"key":"1511_CR17","doi-asserted-by":"publisher","first-page":"113321","DOI":"10.1016\/j.ejca.2023.113321","volume":"194","author":"C Rasola","year":"2023","unstructured":"Rasola C, Laurent-Puig P, Andre T, Falcoz A, Lepage C, Aparicio T, Bouche O, Lievre A, Mineur L, Bennouna J, et al. Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer. Eur J Cancer. 2023;194:113321.","journal-title":"Eur J Cancer"},{"issue":"9","key":"1511_CR18","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/annonc\/mdz208","volume":"30","author":"J Taieb","year":"2019","unstructured":"Taieb J, Shi Q, Pederson L, Alberts S, Wolmark N, Van Cutsem E, de Gramont A, Kerr R, Grothey A, Lonardi S, et al. Prognosis of microsatellite instability and\/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies. Ann Oncol. 2019;30(9):1466\u201371.","journal-title":"Ann Oncol"},{"issue":"8","key":"1511_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/annonc\/mdz159","volume":"30","author":"MK Fink","year":"2019","unstructured":"Fink MK. Does adjuvant therapy reduce postmetastatic survival? Ann Oncol. 2019;30(8):1184\u20138.","journal-title":"Ann Oncol"},{"issue":"4","key":"1511_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/SLA.0b013e31826b4dcc","volume":"256","author":"A Andreou","year":"2012","unstructured":"Andreou A, Kopetz S, Maru DM, Chen SS, Zimmitti G, Brouquet A, Shindoh J, Curley SA, Garrett C, Overman MJ, et al. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg. 2012;256(4):642\u201350.","journal-title":"Ann Surg"},{"issue":"34","key":"1511_CR21","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1200\/JCO.21.01032","volume":"39","author":"Y Kanemitsu","year":"2021","unstructured":"Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Hamaguchi T, Shida D, Ohue M, Komori K, Shiomi A, Shiozawa M, et al. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG0603): a phase II or III randomized controlled trial. J Clin Oncol. 2021;39(34):3789\u201399.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1511_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12885-019-5650-0","volume":"19","author":"DW Lee","year":"2019","unstructured":"Lee DW, Han SW, Cha Y, Bae JM, Kim HP, Lyu J, Han H, Kim H, Jang H, Bang D, et al. Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy. BMC Cancer. 2019;19(1):421.","journal-title":"BMC Cancer"},{"issue":"7","key":"1511_CR23","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.dld.2023.11.041","volume":"56","author":"V Balboa-Barreiro","year":"2024","unstructured":"Balboa-Barreiro V, Pertega-Diaz S, Garcia-Rodriguez T, Gonzalez-Martin C, Pardeiro-Pertega R, Yanez-Gonzalez-Dopeso L, Seoane-Pillado T. Colorectal cancer recurrence and its impact on survival after curative surgery: An analysis based on multistate models. Dig Liver Dis. 2024;56(7):1229\u201336.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"1511_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.23922\/jarc.2019-018","volume":"3","author":"Japanese Society for Cancer of the C, Rectum","year":"2019","unstructured":"Japanese Society for Cancer of the C, Rectum. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication]. J Anus Rectum Colon. 2019;3(4):175\u201395.","journal-title":"J Anus Rectum Colon"},{"issue":"11","key":"1511_CR25","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.21873\/anticanres.16061","volume":"42","author":"N Yamauchi","year":"2022","unstructured":"Yamauchi N, Matsuda T, Sawad R, Hasegawa H, Yamashita K, Harada H, Urakawa N, Goto H, Kanaji S, Oshikiri T, et al. Clinical Significance of Early Recurrence After Curative Resection of Colorectal Cancer. Anticancer Res. 2022;42(11):5553\u20139.","journal-title":"Anticancer Res"},{"issue":"7","key":"1511_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/jjco\/hyae035","volume":"54","author":"M Inoue","year":"2024","unstructured":"Inoue M, Kanemitsu Y, Tsukamoto S, Moritani K, Takamizawa Y, Daiko H. Prognostic impact of primary tumour location after curative resection in Stage I-III colorectal cancer: a single-centre retrospective study. Jpn J Clin Oncol. 2024;54(7):753\u201360.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"1511_CR27","first-page":"e53","volume":"20","author":"S Malakorn","year":"2021","unstructured":"Malakorn S, Ouchi A, Hu CY, Sandhu L, Dasari A, You YN, Kopetz ES, Ellis LM, Chang GJ. Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer. Clin Colorectal Cancer. 2021;20(1):e53\u201360.","journal-title":"Clin Colorectal Cancer"},{"issue":"5","key":"1511_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/SLA.0000000000002206","volume":"267","author":"S Ishihara","year":"2018","unstructured":"Ishihara S, Murono K, Sasaki K, Yasuda K, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Hata K, et al. Impact of Primary Tumor Location on Postoperative Recurrence and Subsequent Prognosis in Nonmetastatic Colon Cancers: A Multicenter Retrospective Study Using a Propensity Score Analysis. Ann Surg. 2018;267(5):917\u201321.","journal-title":"Ann Surg"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01511-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:16:26Z","timestamp":1782458186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01511-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01511-0","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The Institutional Review Board of Fukushima Medical University approved this retrospective study (30148 and REC2024-041), and waived the requirement for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}